Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Histopathology ; 53(6): 707-14, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19102010

RESUMO

AIMS: To assess the pathological findings in lobectomy specimens, to correlate them with smoking history and postoperative course and to compare the findings with those in smoking-related interstitial lung disease. METHODS AND RESULTS: Patients who had undergone lobectomy for lung cancer were reviewed. Subjects included 230 non-smokers and 587 smokers, of whom 572 had a known smoking index (SI). They were classified into mild, moderate and heavy smokers. Centrilobular emphysema (CLE), respiratory bronchiolitis, airspace enlargement with fibrosis (AEF), the presence of foci resembling usual interstitial pneumonia pattern (UIP/P) and the rate of postoperative respiratory failure were assessed. The incidence of AEF was 6.5% in mild smokers, and 17.7% in moderate smokers (P < 0.01) with lower lobe predominance. There were significant correlations (P < 0.01) between AEF and CLE and AEF and UIP/P. The rate of respiratory failure after lobectomy was 6%, and 10% in patients having UIP/P with or without AEF, but was not seen in patients with AEF alone (P < 0.01). CONCLUSIONS: AEF is an important smoking-related change in the lung that appears to correlate with the smoking history, and its distinction from UIP/P may be important.


Assuntos
Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/cirurgia , Pulmão/patologia , Fumar/efeitos adversos , Idoso , Feminino , Humanos , Doenças Pulmonares Intersticiais/patologia , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório
2.
Surg Gynecol Obstet ; 158(1): 93-4, 1984 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-6691172

RESUMO

A subcutaneous portal reservoir system has been developed for infusing chemotherapeutic agents intraportally to treat nonresectable metastasis to the liver. We have discussed the clinical use and effectiveness of the system.


Assuntos
Antineoplásicos/administração & dosagem , Carcinoma/tratamento farmacológico , Infusões Parenterais/métodos , Neoplasias Hepáticas/tratamento farmacológico , Veia Porta , Carcinoma/secundário , Humanos , Neoplasias Hepáticas/secundário
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...